… (PM)-coated core-shell nanovehicle (designated PM-NV) for … deliver anticancer therapeutics
to their most active destinations. To demonstrate our hypothesis, we loaded two anticancer …

… can be used for targeted anticancer drug delivery, due to their … be utilized to deliver anticancer
drugs or platelets inhibitors … ) (PLGA)-based platelet-mimicking nanoparticle to deliver the …

… Future studies are planned to confirm the in vivo targeting capacity of CCM@PL as well
as in vivo anticancer effect. Thus far, the anticancer effect of the emerging biomimetic …

… between vascular disruption and platelet-mimicking biotaxis for the … antitumor potency
via the biologically driven cooperation among intratumoral vascular disruption, platelet-mimicking …

… Nanoplatelets represent a new class of living nano-vehicles that may efficiently target
and deliver therapeutic agents and imaging probes to diseased tissues including tumors. …

Breast cancer is a major threat to health and lives of females. Biomimetic nanotechnology
brought brighter hope for early diagnosis and treatment of breast cancer. Here, we proposed a …

… Her research focuses on the development of anticancer drug … Hu et al. exploited a
platelet-mimicking nanovehicle (PM-NV) … of platelet and platelet-mimicking nanomaterial-based …

… In conclusion, we hypothesize that nanovehicles (PLTM-HMSNs) coated by platelet … anticancer
drugs to the most active areas. To prove our hypothesis, we loaded two anticancer drugs, …

Cancer metastasis is the leading cause of cancer-related deaths. The indispensable role of
platelets in tumor metastasis inspires the targeted delivery strategy by using platelet-drug …

… Focusing on restructuring the tumor microenvironment to enhance the efficacy of
chemotherapy, our findings represent a novel method for augmenting the antitumor effect of …